Journal of Neuropsychiatry (J NEUROPSYCH CLIN N)

Publications in this journal

• Article: Treatment of akinetic mutism with intramuscular olanzapine: a case series.

  David R Spiegel, Daniel P Casella, David M Callender, Neetu Dhadwal
  [show abstract] [hide abstract]
  ABSTRACT: Akinetic mutism is a wakeful state of severe apathy and paucity of volitional movement. Evidence indicates a possible dopaminergic hypofunction within the anterior cingulate cortex. The authors present three cases of acute onset akinetic mutism successfully treated with intramuscular olanzapine.
  Journal of Neuropsychiatry 02/2008; 20(1):93-5.
• Source

  Available from: psychiatryonline.org

  Article: Memantine in major depression with catatonic features.

  Camilo Munoz, Natalia Yulan, Victoria Achaval, Francisco Appiani, Brendan T Carroll
  Journal of Neuropsychiatry 02/2008; 20(1):119-20.
• Source

  Available from: psychiatryonline.org

  Article: Donepezil induced hypomania.

  Vani Rao, Linda Ovitt, Beatrice Robbins
  Journal of Neuropsychiatry 02/2008; 20(1):107.
• Source

  Available from: psychiatryonline.org

  Article: Lamotrigine for the treatment of impulsive aggression and affective symptoms in a patient with borderline personality disorder comorbid with body dysmorphic disorder.

  Zoran M Pavlovic
  Journal of Neuropsychiatry 02/2008; 20(1):121-2.
• Source

  Available from: psychiatryonline.org

  Article: The neuroprotective effect of olanzapine.

  Burak Yulug, Mustafa Bakar, Erol Ozan
  Journal of Neuropsychiatry 02/2008; 20(1):107-8.
• Article: Brain damage after preischemic locomotor activity.

  Burak Yulug, Mustafa Bakar, Erol Ozan
  Journal of Neuropsychiatry 02/2008; 20(1):123-4.
• Source

  Available from: decipheringthebrain.com

  Article: Behavioral reactivity and addiction: the adaptation of behavioral response to reward opportunities.

  Jodie A Trafton, Elizabeth V Gifford
  [show abstract] [hide abstract]
  ABSTRACT: Persons recovering from addiction must refrain from drug use even when the opportunity to use exists. Understanding how behavioral response to drug reward opportunities is modified is key to treating addiction. Most effective behavioral therapies encourage patients to increase reinforcement opportunities by engaging unidentified sources of nondrug reward. The authors integrate transdisciplinary research on the brain and behavioral effects of increasing reward availability to demonstrate one neurobiological mechanism by which behavioral therapies help patients abstain. Explicating neurobiological processes underlying psychotherapy provides predictions about the interaction between dopaminergic medications and therapy and the impact of individual differences in dopamine receptor expression on addiction vulnerability.
  Journal of Neuropsychiatry 02/2008; 20(1):23-35.
• Article: Traumatic brain injury, Apolipoprotein E-epsilon4, and cognition in older adults: a two-year longitudinal study.

  Mark Rapoport, Uri Wolf, Nathan Herrmann, Alex Kiss, Prathiba Shammi, Marciano Reis, Andrea Phillips, Anthony Feinstein
  [show abstract] [hide abstract]
  ABSTRACT: Patients with mild-to-moderate traumatic brain injury (TBI) (N=69) were compared with age-, gender-, and education-matched healthy control group subjects (N=79) on performance of neuropsychological tests at one and 2 years following injury, and informant-rated functional abilities. All subjects were assessed for the presence of the Apolipoprotein E-epsilon4 (APOE-epsilon4) allele and rated for "mild cognitive impairment" (MCI) or dementia. Traumatic brain injury patients were no different from the comparison group on measures of cognition or functional impairment. Traumatic brain injury was not associated with higher rates of amnestic mild cognitive impairment or dementia, and APOE-epsilon4 was not associated with cognition.
  Journal of Neuropsychiatry 02/2008; 20(1):68-73.
• Article: Electroencephalographic cerebral dysrhythmic abnormalities in the trinity of nonepileptic general population, neuropsychiatric, and neurobehavioral disorders.

  Bhaskara P Shelley, Michael R Trimble, Nash N Boutros
  [show abstract] [hide abstract]
  ABSTRACT: Subclinical electroencephalographic epileptiform discharges in neurobehavioral disorders are not uncommon. The clinical significance and behavioral, diagnostic, and therapeutic implications of this EEG cerebral dysrhythmia have not been fully examined. Currently the only connotation for distinctive epileptiform electroencephalographic patterns is epileptic seizures. Given the prevailing dogma of not treating EEGs, these potential aberrations are either disregarded as irrelevant or are misattributed to indicate epilepsy. This article reappraises the literature on paroxysmal EEG dysrhythmia in normative studies of the "healthy" nonepileptic general populations, neuropsychiatry, and in neurobehavioral disorders. These EEG aberrations may be reflective of underlying morpho-functional brain abnormalities that underpin various neurobehavioral disturbances.
  Journal of Neuropsychiatry 02/2008; 20(1):7-22.
• Article: Changes in regional cerebral blood flow after repetitive transcranial magnetic stimulation of the left dorsolateral prefrontal cortex in treatment-resistant depression.

  Shinsuke Kito, Kenichi Fujita, Yoshihiko Koga
  [show abstract] [hide abstract]
  ABSTRACT: High-frequency repetitive transcranial magnetic stimulation (rTMS) of the left dorsolateral prefrontal cortex is effective in treatment-resistant depression, although its mechanism is still not completely elucidated. To clarify the neuroanatomical alteration of function elicited by rTMS, single photon emission computed tomography (SPECT) with (99m)Tc-ECD was performed on 12 male inpatients with treatment-resistant unipolar depression before and after high-frequency rTMS of the left dorsolateral prefrontal cortex. These results suggest that the manifestation of the antidepressant effect of high-frequency rTMS is associated with changes in the neuroanatomical function of the left dorsolateral prefrontal cortex as well as of the limbic-paralimbic region, including the ipsilateral subgenual cingulate, and the basal ganglia.
  Journal of Neuropsychiatry 02/2008; 20(1):74-80.
• Article: Content-specific delusions from right caudate lacunar stroke: association with prefrontal hypometabolism.

  Aaron M McMurtray, David L Sultzer, Lorena Monserratt, Tuty Yeo, Mario F Mendez
  [show abstract] [hide abstract]
  ABSTRACT: Patients with caudate lesions can present with content-specific delusions, possibly due to disruption of frontosubcortical circuits connecting the frontal lobes with the basal ganglia. This study included eight patients who presented with content-specific delusions after right caudate stroke and an equal number of matched controls, without stroke or delusions. Compared to controls, patients with caudate lesions performed less well on tests of memory, abstract reasoning, and frontal executive functions, and had significantly reduced metabolism in the inferior prefrontal cortex. These patients suggest an etiological relationship between alterations in inferior prefrontal functions and the development of content-specific delusions.
  Journal of Neuropsychiatry 02/2008; 20(1):62-7.
• Article: Psychiatric manifestations in Wilson's disease: a cross-sectional analysis.

  A Shanmugiah, S Sinha, A B Taly, L K Prashanth, M Tomar, G R Arunodaya, Janardhana Y C Reddy, S Khanna
  [show abstract] [hide abstract]
  ABSTRACT: Behavioral and psychiatric abnormalities in Wilson's disease (WD) have a variable frequency and spectrum. This study involved evaluation of the psychiatric comorbidities in patients of Wilson's disease, using structured clinical interview for DSM-IV Axis-I disorders (SCID). Among the 50 confirmed patients with Wilson's disease recruited for this study, 12 patients (24%) fulfilled the diagnostic criteria for syndromic psychiatric diagnosis: bipolar affective disorder (18%), major depression (4%), and dysthymia (2%). Formal assessment of psychopathology in all patients with Wilson's disease may have therapeutic significance.
  Journal of Neuropsychiatry 02/2008; 20(1):81-5.
• Article: "Denkfaulheit" in frontotemporal dementia: a preliminary analysis.

  Mario F Mendez, Jill S Shapira, Eliot A Licht
  [show abstract] [hide abstract]
  ABSTRACT: The initial recognition of frontotemporal dementia is often difficult. Frontotemporal dementia presents with subtle personality changes in the absence of a definitive biomarker. The authors report an analysis of cognitive shallowness, or "Denkfaulheit," in patients with frontotemporal dementia early in its course.
  Journal of Neuropsychiatry 02/2008; 20(2):219-22.
• Article: Sex-dependent hippocampal volume reductions in schizophrenia relate to episodic memory deficits.

  Cornelia Exner, Barbara Nehrkorn, Vera Martin, Martin Huber, Kiyoshi Shiratori, Winfried Rief
  [show abstract] [hide abstract]
  ABSTRACT: Morphological abnormalities of the hippocampus might form the neurobiological basis of memory dysfunction in schizophrenia. Hippocampal volume was found to be bilaterally reduced in male, but not in female, subjects with schizophrenia. Right hippocampal volume was significantly related to impaired visual learning.
  Journal of Neuropsychiatry 02/2008; 20(2):227-30.
• Source

  Available from: psychiatryonline.org

  Article: Paroxysmal kinesigenic dyskinesia and cervical disc prolapse with cord compression: more than a coincidence?

  Burak Yulug, Mustafa Bakar, Haluk Ozer H, Müslüm Yilmaz, Bülent Unlü
  Journal of Neuropsychiatry 02/2008; 20(2):237-9.
• Source

  Available from: psychiatryonline.org

  Article: Neuroimaging correlates of chronic delusional jealousy after right cerebral infarction.

  J-P Luauté, O Saladini, J Luauté
  Journal of Neuropsychiatry 02/2008; 20(2):245-7.
• Article: Topiramate-induced palinopsia.

  Leonardo F Fontenelle
  Journal of Neuropsychiatry 02/2008; 20(2):249-50.
• Article: Multiple sclerosis, cannabinoids, and cognition.

  Panagiotis Papathanasopoulos, Lambros Messinis, Epameinondas Lyros, Andreas Kastellakis, George Panagis
  [show abstract] [hide abstract]
  ABSTRACT: There is increasing interest in the therapeutic potential of cannabis-based medicinal extracts in multiple sclerosis. Cognitive deficits that have been attributed to long-term heavy recreational use of cannabis are not necessarily extended to controlled pharmaceutical use of cannabis-based medicinal extracts. Available data indicate that after relatively short-term administration of cannabis-based medicinal extracts no significant cognitive decline occurs. Due to the absence of large scale long-term systematic clinical trials of cannabis-based medicinal extracts in multiple sclerosis therapeutics, however, many issues remain unresolved, including the possible adverse effects of cannabis-based medicinal extracts on cognition. This article critically reviews the current literature and considers the potential for cognitive adverse effects of long-term cannabinoid use in multiple sclerosis therapeutics.
  Journal of Neuropsychiatry 02/2008; 20(1):36-51.
• Article: Reduction in salivary cortisol concentration correlates with resolution of psychosis in Cushing's syndrome.

  Paul C Myhill, Brett A Sillars, Sergio Starkstein, Tibor Annus, Bu B Yeap
  Journal of Neuropsychiatry 02/2008; 20(1):113-5.